Dr. Medhavi Gupta, one of the participants in this past year’s GRACE Patient Education Ambassador Program, shares a fantastic video series on Breast Cancer. For this first series, Dr. Gupta discusses Brain Metastases in Breast Cancer with Dr. Nancy Lin. Dr. Lin is Associate Chief, Division of Breast Oncology at the Susan F. Smith Center for Women’s Cancers, Associate Professor of Medicine and the Director for the Metastatic Breast Cancer Program and the Program for Patients with Breast Cancer Brain Metastases at Harvard In this video, Drs. Gupta and Lin discuss signs and symptoms that may indicate brain metastases in…
Author: Editor
Dr. Medhavi Gupta, one of the participants in this past year’s GRACE Patient Education Ambassador Program, shares a fantastic video series on Breast Cancer. For this first series, Dr. Gupta discusses Surgical Management in Breast Cancer with Dr. Jessica Young. In this video, Drs. Gupta and Young discuss what to expect after surgery. #breastcancer #surgery #cancerGRACE #genentech #lilly For more, please visit http://cancerGRACE.org/. To join the conversation, visit https://cancergrace.org/forum.
Dr. Medhavi Gupta, one of the participants in this past year’s GRACE Patient Education Ambassador Program, shares a fantastic video series on Breast Cancer. For this first series, Dr. Gupta discusses Brain Metastases in Breast Cancer with Dr. Nancy Lin. Dr. Lin is Associate Chief, Division of Breast Oncology at the Susan F. Smith Center for Women’s Cancers, and Associate Professor of Medicine and the Director for the Metastatic Breast Cancer Program and the Program for Patients with Breast Cancer Brain Metastases at Harvard. In this video, Drs. Gupta and Lin discuss the risks of developing brain metastases in breast…
Dr. Medhavi Gupta, one of the participants in this past year’s GRACE Patient Education Ambassador Program, shares a fantastic video series on Breast Cancer. For this first series, Dr. Gupta discusses Brain Metastases in Breast Cancer with Dr. Nancy Lin. Dr. Lin is Associate Chief, Division of Breast Oncology at the Susan F. Smith Center for Women’s Cancers, Associate Professor of Medicine and the Director for the Metastatic Breast Cancer Program and the Program for Patients with Breast Cancer Brain Metastases at Harvard In this video, Drs. Gupta and Lin discuss the prognosis and impact on survival in breast cancer…
Dr. Medhavi Gupta, one of the participants in this past year’s GRACE Patient Education Ambassador Program, shares a fantastic video series on Breast Cancer. For this first series, Dr. Gupta discusses Surgical Management in Breast Cancer with Dr. Jessica Young. In this video, Drs. Gupta and Young discuss body image and reconstructive surgery. #breastcancer #surgery #cancerGRACE #genentech #lilly For more, please visit http://cancerGRACE.org/. To join the conversation, visit https://cancergrace.org/forum.
Dr. Medhavi Gupta, one of the participants in this past year’s GRACE Patient Education Ambassador Program, shares a fantastic video series on Breast Cancer. For this first series, Dr. Gupta discusses Surgical Management in Breast Cancer with Dr. Jessica Young. In this video, Drs. Gupta and Young discuss what to expect during surgery. #breastcancer #surgery #cancerGRACE #genentech #lilly For more, please visit http://cancerGRACE.org/. To join the conversation, visit https://cancergrace.org/forum.
Dr. Medhavi Gupta, one of the participants in this past year’s GRACE Patient Education Ambassador Program, shares a fantastic video series on Breast Cancer. For this first series, Dr. Gupta discusses Surgical Management in Breast Cancer with Dr. Jessica Young. In this video, Drs. Gupta and Young discuss surgical management in breast cancer, and the surgical removal of lymph nodes – sentinel lymph node biopsy vs. axillary lymph node dissection (ALND). #breastcancer #surgery #cancerGRACE #genentech #lilly For more, please visit http://cancerGRACE.org/. To join the conversation, visit https://cancergrace.org/forum.
Dr. Medhavi Gupta, one of the participants in this past year’s GRACE Patient Education Ambassador Program, shares a fantastic video series on Breast Cancer. For this first series, Dr. Gupta discusses Surgical Management in Breast Cancer with Dr. Jessica Young. In this video, Drs. Gupta and Young discuss surgical management in breast cancer and prophylactic mastectomy on the opposite breast. #breastcancer #surgery #cancerGRACE #genentech #lilly For more, please visit http://cancerGRACE.org/. To join the conversation, visit https://cancergrace.org/forum.
Dr. Medhavi Gupta, one of the participants in this past year’s GRACE Patient Education Ambassador Program, has presented GRACE with a fantastic video series on Breast Cancer. For this first series, Dr. Gupta discusses Surgical Management in Breast Cancer with Dr. Jessica Young. In this video, Drs. Gupta and Young discuss long term outcomes in breast-conserving therapy vs. mastectomy. Many thanks to our sponsors #Lilly and #Genentech! For more, please visit http://cancerGRACE.org/. To join the conversation, visit https://cancergrace.org/forum.
Dr. Medhavi Gupta, one of the participants in this past year’s GRACE Patient Education Ambassador Program, shares a fantastic video series on Breast Cancer. For this first series, Dr. Gupta discusses Surgical Management in Breast Cancer with Dr. Jessica Young. In this video, Drs. Gupta and Young discuss the role of different types of surgery and the management of patients with breast cancer. #breastcancer #surgery #cancerGRACE #genentech #lilly For more, please visit http://cancerGRACE.org/. To join the conversation, visit https://cancergrace.org/forum.
Videos from the 2020 Targeted Therapies Patient Forum are still available! This past event’s live-online presentations and discussions were launched by our Event Chair, Luis E. Raez, MD FACP FCCP, Member of the GRACE Board of Directors, President of the Florida Society of Clinical Oncology (FLASCO), and Chief Scientific Officer & Medical Director at Memorial Cancer Institute. The day-long event featured top oncologists in their field, presenting the most current and emerging information in targeted therapies for patients and caregivers living with lung cancer. In this video from the ALK/ROS session from the event, the panel discusses TKIs for a…
Videos from the 2020 Targeted Therapies Patient Forum are still available! This past event’s live-online presentations and discussions were launched by our Event Chair, Luis E. Raez, MD FACP FCCP, Member of the GRACE Board of Directors, President of the Florida Society of Clinical Oncology (FLASCO), and Chief Scientific Officer & Medical Director at Memorial Cancer Institute. The day-long event featured top oncologists in their field, presenting the most current and emerging information in targeted therapies for patients and caregivers living with lung cancer. In this video from the ALK/ROS session from the event, the panel discusses ROS1+ patients who…
Videos from the 2020 Targeted Therapies Patient Forum are still available! This past event’s live-online presentations and discussions were launched by our Event Chair, Luis E. Raez, MD FACP FCCP, Member of the GRACE Board of Directors, President of the Florida Society of Clinical Oncology (FLASCO), and Chief Scientific Officer & Medical Director at Memorial Cancer Institute. The day-long event featured top oncologists in their field, presenting the most current and emerging information in targeted therapies for patients and caregivers living with lung cancer. In this video from the ALK/ROS session from the event, the panel discusses the differences in…
Videos from the 2020 Targeted Therapies Patient Forum are still available! This past event’s live-online presentations and discussions were launched by our Event Chair, Luis E. Raez, MD FACP FCCP, Member of the GRACE Board of Directors, President of the Florida Society of Clinical Oncology (FLASCO), and Chief Scientific Officer & Medical Director at Memorial Cancer Institute. The day-long event featured top oncologists in their field, presenting the most current and emerging information in targeted therapies for patients and caregivers living with lung cancer. In this video from the ALK/ROS session from the event, the panel discusses how treatment would…
Videos from the 2020 Targeted Therapies Patient Forum are still available! This past event’s live-online presentations and discussions were launched by our Event Chair, Luis E. Raez, MD FACP FCCP, Member of the GRACE Board of Directors, President of the Florida Society of Clinical Oncology (FLASCO), and Chief Scientific Officer & Medical Director at Memorial Cancer Institute. The day-long event featured top oncologists in their field, presenting the most current and emerging information in targeted therapies for patients and caregivers living with lung cancer. In this video from the ALK/ROS session from the event, the panel discusses what we know…
Videos from the 2020 Targeted Therapies Patient Forum are still available! This past event’s live-online presentations and discussions were launched by our Event Chair, Luis E. Raez, MD FACP FCCP, Member of the GRACE Board of Directors, President of the Florida Society of Clinical Oncology (FLASCO), and Chief Scientific Officer & Medical Director at Memorial Cancer Institute. The day-long event featured top oncologists in their field, presenting the most current and emerging information in targeted therapies for patients and caregivers living with lung cancer. In this video from the ALK/ROS session from the event, the panel discusses whether ROS1+ patients…
Videos from the 2020 Targeted Therapies Patient Forum are still available! This past event’s live-online presentations and discussions were launched by our Event Chair, Luis E. Raez, MD FACP FCCP, Member of the GRACE Board of Directors, President of the Florida Society of Clinical Oncology (FLASCO), and Chief Scientific Officer & Medical Director at Memorial Cancer Institute. The day-long event featured top oncologists in their field, presenting the most current and emerging information in targeted therapies for patients and caregivers living with lung cancer. In this video from the ALK/ROS session from the event, the panel discusses using circulating tumor…
Videos from the 2020 Targeted Therapies Patient Forum are still available! This past event’s live-online presentations and discussions were launched by our Event Chair, Luis E. Raez, MD FACP FCCP, Member of the GRACE Board of Directors, President of the Florida Society of Clinical Oncology (FLASCO), and Chief Scientific Officer & Medical Director at Memorial Cancer Institute. The day-long event featured top oncologists in their field, presenting the most current and emerging information in targeted therapies for patients and caregivers living with lung cancer. In this video from the ALK session from the event, the panel discusses the next treatment…
Videos from the 2020 Targeted Therapies Patient Forum are still available! This past event’s live-online presentations and discussions were launched by our Event Chair, Luis E. Raez, MD FACP FCCP, Member of the GRACE Board of Directors, President of the Florida Society of Clinical Oncology (FLASCO), and Chief Scientific Officer & Medical Director at Memorial Cancer Institute. The day-long event featured top oncologists in their field, presenting the most current and emerging information in targeted therapies for patients and caregivers living with lung cancer. In this video from the ALK session from the event, the panel discusses what is next…
Videos from the 2020 Targeted Therapies Patient Forum are still available! This past event’s live-online presentations and discussions were launched by our Event Chair, Luis E. Raez, MD FACP FCCP, Member of the GRACE Board of Directors, President of the Florida Society of Clinical Oncology (FLASCO), and Chief Scientific Officer & Medical Director at Memorial Cancer Institute. The day-long event featured top oncologists in their field, presenting the most current and emerging information in targeted therapies for patients and caregivers living with lung cancer. In this video from the ROS session from the event, the panel discusses what information we…
Join us for the 2021 Targeted Therapies Patient Forum, presented Live-Online on July 17, 2021, at 10:00 am eastern time! More information is available at cancerGRACE.org. But meanwhile — Videos from the 2020 Targeted Therapies Patient Forum are still available! This past event’s live-online presentations and discussions were launched by our Event Chair, Luis E. Raez, MD FACP FCCP, Member of the GRACE Board of Directors, President of the Florida Society of Clinical Oncology (FLASCO), and Chief Scientific Officer & Medical Director at Memorial Cancer Institute. The day-long event featured top oncologists in their field, presenting the most current and…
Join us for the 2021 Targeted Therapies Patient Forum, presented Live-Online on July 17, 2021, at 10:00 am eastern time! More information is available at cancerGRACE.org. But meanwhile — Videos from the 2020 Targeted Therapies Patient Forum are still available! This past event’s live-online presentations and discussions were launched by our Event Chair, Luis E. Raez, MD FACP FCCP, Member of the GRACE Board of Directors, President of the Florida Society of Clinical Oncology (FLASCO), and Chief Scientific Officer & Medical Director at Memorial Cancer Institute. The day-long event featured top oncologists in their field, presenting the most current and…
Videos from the 2020 Targeted Therapies Patient Forum are still available! This past event’s live-online presentations and discussions were launched by our Event Chair, Luis E. Raez, MD FACP FCCP, Member of the GRACE Board of Directors, President of the Florida Society of Clinical Oncology (FLASCO), and Chief Scientific Officer & Medical Director at Memorial Cancer Institute. The day-long event featured top oncologists in their field, presenting the most current and emerging information in targeted therapies for patients and caregivers living with lung cancer. In this video from the ALK session from the event, the panel discusses the reducing dosage…
Join us for the 2021 Targeted Therapies Patient Forum, presented Live-Online on July 17, 2021, at 10:00 am eastern time! But meanwhile — Videos from the 2020 Targeted Therapies Patient Forum are still available! This past event’s live-online presentations and discussions were launched by our Event Chair, Luis E. Raez, MD FACP FCCP, Member of the GRACE Board of Directors, President of the Florida Society of Clinical Oncology (FLASCO), and Chief Scientific Officer & Medical Director at Memorial Cancer Institute. The day-long event featured top oncologists in their field, presenting the most current and emerging information in targeted therapies for…
Join us for the 2021 Targeted Therapies Patient Forum, presented Live-Online on July 17, 2021, at 10:00 am eastern time! But meanwhile — Videos from the 2020 Targeted Therapies Patient Forum are still available! This past event’s live-online presentations and discussions were launched by our Event Chair, Luis E. Raez, MD FACP FCCP, Member of the GRACE Board of Directors, President of the Florida Society of Clinical Oncology (FLASCO), and Chief Scientific Officer & Medical Director at Memorial Cancer Institute. The day-long event featured top oncologists in their field, presenting the most current and emerging information in targeted therapies for…
Join us for the 2021 Targeted Therapies Patient Forum, presented Live-Online on July 17, 2021, at 10:00 am eastern time! More information is available at cancerGRACE.org. But meanwhile — Videos from the 2020 Targeted Therapies Patient Forum are still available! This past event’s live-online presentations and discussions were launched by our Event Chair, Luis E. Raez, MD FACP FCCP, Member of the GRACE Board of Directors, President of the Florida Society of Clinical Oncology (FLASCO), and Chief Scientific Officer & Medical Director at Memorial Cancer Institute. The day-long event featured top oncologists in their field, presenting the most current and…
Join us for the 2021 Targeted Therapies Patient Forum, presented Live-Online on July 17, 2021, at 10:00 am eastern time! More information is available at cancerGRACE.org. But meanwhile — Videos from the 2020 Targeted Therapies Patient Forum are still available! This past event’s live-online presentations and discussions were launched by our Event Chair, Luis E. Raez, MD FACP FCCP, Member of the GRACE Board of Directors, President of the Florida Society of Clinical Oncology (FLASCO), and Chief Scientific Officer & Medical Director at Memorial Cancer Institute. The day-long event featured top oncologists in their field, presenting the most current and…
Join us for the 2021 Targeted Therapies Patient Forum, presented Live-Online on July 17, 2021, at 10:00 am eastern time! More information is available at cancerGRACE.org. But meanwhile — Videos from the 2020 Targeted Therapies Patient Forum are still available! This past event’s live-online presentations and discussions were launched by our Event Chair, Luis E. Raez, MD FACP FCCP, Member of the GRACE Board of Directors, President of the Florida Society of Clinical Oncology (FLASCO), and Chief Scientific Officer & Medical Director at Memorial Cancer Institute. The day-long event featured top oncologists in their field, presenting the most current and…
Join us for the 2021 Targeted Therapies Patient Forum, presented Live-Online on July 17, 2021, at 10:00 am eastern time! More information is available at cancerGRACE.org. But meanwhile — Videos from the 2020 Targeted Therapies Patient Forum are still available! This past event’s live-online presentations and discussions were launched by our Event Chair, Luis E. Raez, MD FACP FCCP, Member of the GRACE Board of Directors, President of the Florida Society of Clinical Oncology (FLASCO), and Chief Scientific Officer & Medical Director at Memorial Cancer Institute. The day-long event featured top oncologists in their field, presenting the most current and…
En esta serie de videos, los Dres. Luis Raez, Estalemari Rodriguez y Ticiana Leal tener discusiones sinceras sobre el cáncer y COVID-19. En este tiempo continuo de distanciamiento social y limitación de la exposición clÃnica, los médicos se sentaron para discutir algunas de las preguntas que todos escuchamos sobre estos tiempos sin precedentes y cómo afectan principalmente a los pacientes con cáncer. En este video, la discusión gira en torno al impacto de la pandemia COVID-19 en la atención de los pacientes con cáncer. Gracias a Exelixis y Merck por su apoyo a este programa. Para obtener más información, visite…
En esta serie de videos, los Dres. Luis Raez, Estalemari Rodriguez y Ticiana Leal tener discusiones sinceras sobre el cáncer y COVID-19. En este tiempo continuo de distanciamiento social y limitación de la exposición clÃnica, los médicos se sentaron a discutir algunas de las preguntas que todos escuchamos con respecto a estos tiempos sin precedentes y cómo afectan principalmente a los pacientes con cáncer. En este video, la discusión gira en torno al uso de la telemedicina en el tratamiento de pacientes con cáncer. Gracias a #Exelixis y #Merck por su apoyo a este programa. Para obtener más información, visite…
En esta serie de videos, los Dres. Luis Raez, Estalemari RodrÃguez y Ticiana Leal tienen conversaciones sinceras sobre el cáncer y el COVID-19. En este tiempo continuo de distanciamiento social y limitación de la exposición clÃnica, los médicos se sentaron a discutir algunas de las preguntas que todos escuchamos con respecto a estos tiempos sin precedentes y cómo afectan principalmente a los pacientes con cáncer. En este video, la discusión gira en torno al uso de la vacuna COVID-19 en pacientes con cáncer. Gracias a #Exelixis y #Merck por su apoyo a este programa. Para obtener más información, visite https://cancergrace.org.…
Richard A. Van Etten MD, Ph.D., Director of the NCI-designated Chao Family Comprehensive Cancer Center and member of the Division of Hematology/Oncology at the University of California, Irvine, Senior Associate Dean & Associate Vice Chancellor for Cancer University of California, Irvine speaks about Helio Health and Fulgent Genetics Announce Late-Breaking Positive Performance Data of HelioLiverâ„¢ for Early Liver Cancer Detection.Link to Article:https://www.prnewswire.com/news-releases/helio-health-and-fulgent-genetics-announce-late-breaking-positive-performance-data-of-helioliver-for-early-liver-cancer-detection-301418252.htmlHelio Health and its commercial partner, Fulgent Genetics, Inc., presented fresh data at AASLD today proving the effectiveness of HelioLiver in detecting hepatocellular carcinoma in its early stages (HCC). HelioLiver’s sensitivity was 76 percent in early-stage HCC and 85…
Richard A. Van Etten MD, Ph.D., Director of the NCI-designated Chao Family Comprehensive Cancer Center and member of the Division of Hematology/Oncology at the University of California, Irvine, Senior Associate Dean & Associate Vice Chancellor for Cancer University of California, Irvine speaks about Helio Health and Fulgent Genetics Announce Late-Breaking Positive Performance Data of HelioLiverâ„¢ for Early Liver Cancer Detection.Link to Article:https://www.prnewswire.com/news-releases/helio-health-and-fulgent-genetics-announce-late-breaking-positive-performance-data-of-helioliver-for-early-liver-cancer-detection-301418252.htmlHelio Health and its commercial partner, Fulgent Genetics, Inc., presented fresh data at AASLD today proving the effectiveness of HelioLiver in detecting hepatocellular carcinoma in its early stages (HCC). HelioLiver’s sensitivity was 76 percent in early-stage HCC and 85…
Philip O. Scumpia, MD, Ph.D. and Professor Aydogan Ozcan, Ph.D. from UCLA Health and UCLA Samueli Electrical & Computer Engineering speak about New Imaging Technology Developed by UCLA Research Team May Reduce Need for Skin Biopsies.Link to Article:https://samueli.ucla.edu/new-imaging-technology-developed-by-ucla-research-team-may-reduce-need-for-skin-biopsies/Your dermatologist takes photographs of a suspicious-looking lesion and rapidly produces a detailed, microscopic image of the skin instead of surgically extracting a sample of skin, sending it to a lab, and waiting several days for findings.According to a new article published today in Light: Science & Applications, a journal of the Springer Nature Group, this could become commonplace in clinics as a…
Philip O. Scumpia, MD, Ph.D. and Professor Aydogan Ozcan, Ph.D. from UCLA Health and UCLA Samueli Electrical & Computer Engineering speak about New Imaging Technology Developed by UCLA Research Team May Reduce Need for Skin Biopsies.Link to Article:https://samueli.ucla.edu/new-imaging-technology-developed-by-ucla-research-team-may-reduce-need-for-skin-biopsies/Your dermatologist takes photographs of a suspicious-looking lesion and rapidly produces a detailed, microscopic image of the skin instead of surgically extracting a sample of skin, sending it to a lab, and waiting several days for findings.According to a new article published today in Light: Science & Applications, a journal of the Springer Nature Group, this could become commonplace in clinics as a…
Kevan Shokat, Ph.D., Professor, Department of Cellular and Molecular Pharmacology, at the University of California, San Francisco, and Investigator of the Howard Hughes Medical Institute for discovering a method to inhibit the mutant KRAS protein – a common driver of the growth of lung cancer as well as colorectal and pancreatic cancer. Speaks about Kevan Shokat Ph.D. To Be Awarded The First SWCRF Breakthrough Science Award.Link to Article:https://www.waxmancancer.org/about-us/newsroom/press-releases/kevan-shokat-ph-d-to-be-awarded-the-first-swcrf-breakthrough-science-award/Dr. Kevan Shokat, Professor of Cellular and Molecular Pharmacology at the University of California, San Francisco, and Investigator of the Howard Hughes Medical Institute, will receive the Samuel Waxman Cancer Research Foundation’s first…
John Mascarenhas, MD from the Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai speaks about the U.S. FDA Approves BESREMi® (ropeginterferon alfa-2b-njft) as the Only Interferon for Adults With Polycythemia Vera.Link to Abstract:https://www.businesswire.com/news/home/20211112005909/en/U.S.-FDA-Approves-BESREMi%C2%AE-ropeginterferon-alfa-2b-njft-as-the-Only-Interferon-for-Adults-With-Polycythemia-VeraThe US Food and Drug Administration (FDA) has approved BESREMi® (ropeginterferon alfa-2b-njft) for the treatment of adults with polycythemia vera. PharmaEssentia Corporation, a global biopharmaceutical innovator based in Taiwan, is leveraging deep expertise and proven scientific principles to deliver new biologics in hematology and oncology (PV).BESREMi is a novel monopegylated, long-acting interferon that has been shown to have cellular effects on polycythemia vera bone marrow. BESREMi…
John Mascarenhas, MD from the Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai speaks about the U.S. FDA Approves BESREMi® (ropeginterferon alfa-2b-njft) as the Only Interferon for Adults With Polycythemia Vera.Link to Abstract:https://www.businesswire.com/news/home/20211112005909/en/U.S.-FDA-Approves-BESREMi%C2%AE-ropeginterferon-alfa-2b-njft-as-the-Only-Interferon-for-Adults-With-Polycythemia-VeraThe US Food and Drug Administration (FDA) has approved BESREMi® (ropeginterferon alfa-2b-njft) for the treatment of adults with polycythemia vera. PharmaEssentia Corporation, a global biopharmaceutical innovator based in Taiwan, is leveraging deep expertise and proven scientific principles to deliver new biologics in hematology and oncology (PV).BESREMi is a novel monopegylated, long-acting interferon that has been shown to have cellular effects on polycythemia vera bone marrow. BESREMi…
Kevan Shokat, Ph.D., Professor, Department of Cellular and Molecular Pharmacology, at the University of California, San Francisco, and Investigator of the Howard Hughes Medical Institute for discovering a method to inhibit the mutant KRAS protein – a common driver of the growth of lung cancer as well as colorectal and pancreatic cancer. Speaks about Kevan Shokat Ph.D. To Be Awarded The First SWCRF Breakthrough Science Award.Link to Article:https://www.waxmancancer.org/about-us/newsroom/press-releases/kevan-shokat-ph-d-to-be-awarded-the-first-swcrf-breakthrough-science-award/Dr. Kevan Shokat, Professor of Cellular and Molecular Pharmacology at the University of California, San Francisco, and Investigator of the Howard Hughes Medical Institute, will receive the Samuel Waxman Cancer Research Foundation’s first…
Dea Slade, BSc, MSc, Ph.D., Junior group leader, Max F. Perutz Laboratories, University of Vienna speaks about PHF3 regulates neuronal gene expression through the Pol II CTD reader domain SPOC.Link to Abstract:https://www.nature.com/articles/s41467-021-26360-2Abstract:The C-terminal domain (CTD) of RNA polymerase II (Pol IIbiggest )’s subunit is a transcription and RNA processing control center. PHD-finger protein 3 (PHF3) is a transcription and mRNA stability regulator that binds onto the Pol II CTD via its SPOC domain. SPOC is a CTD reader domain that binds two phosphorylated Serine-2 tags in neighboring CTD repeats preferentially. PHF3 promotes the separation of phosphorylated Pol II into liquid…
Dea Slade, BSc, MSc, Ph.D., Junior group leader, Max F. Perutz Laboratories, University of Vienna speaks about PHF3 regulates neuronal gene expression through the Pol II CTD reader domain SPOC.Link to Abstract:https://www.nature.com/articles/s41467-021-26360-2Abstract:The C-terminal domain (CTD) of RNA polymerase II (Pol IIbiggest )’s subunit is a transcription and RNA processing control center. PHD-finger protein 3 (PHF3) is a transcription and mRNA stability regulator that binds onto the Pol II CTD via its SPOC domain. SPOC is a CTD reader domain that binds two phosphorylated Serine-2 tags in neighboring CTD repeats preferentially. PHF3 promotes the separation of phosphorylated Pol II into liquid…
Dr. Erika Hamilton of Sarah Cannon Research Institute chats with Drs. West & Aggarwal about how clinical trials & medical practice have changed after COVID-19, how the field of breast cancer has evolved, & how social media has created a global community.
Oscar Mesa, MD, MSC, Global Director, Health Economics, outcomes research and Market Access Critical care at Mallinckrodt. Speaks about Mallinckrodt and Terumo Blood and Cell Technologies Announce Positive Recommendations in Australia for Public Funding of UVADEX® (methoxsalen) for ECP Administration with the THERAKOS® CELLEX® Photopheresis System for Chronic Graft Versus Host Disease (cGvHD) in Adults.Link to Article:https://www.mallinckrodt.com/about/news-and-media/news-detail/?id=28736https://therakos.eu/Mallinckrodt plc (OTCMKTS: MNKKQ), a global biopharmaceutical company, and Terumo Blood and Cell Technologies, a global leader in blood component, therapeutic apheresis, and cellular technologies, as well as the exclusive distributor of the Therakos extracorporeal photopheresis (ECP) platform in Australia, announced today that the…
Oscar Mesa, MD, MSC, Global Director, Health Economics, outcomes research and Market Access Critical care at Mallinckrodt. Speaks about Mallinckrodt and Terumo Blood and Cell Technologies Announce Positive Recommendations in Australia for Public Funding of UVADEX® (methoxsalen) for ECP Administration with the THERAKOS® CELLEX® Photopheresis System for Chronic Graft Versus Host Disease (cGvHD) in Adults.Link to Article:https://www.mallinckrodt.com/about/news-and-media/news-detail/?id=28736https://therakos.eu/Mallinckrodt plc (OTCMKTS: MNKKQ), a global biopharmaceutical company, and Terumo Blood and Cell Technologies, a global leader in blood component, therapeutic apheresis, and cellular technologies, as well as the exclusive distributor of the Therakos extracorporeal photopheresis (ECP) platform in Australia, announced today that the…
Ethan Basch, MD, MSc from Lineberger Comprehensive Cancer Center, University of North Carolina speaks about Clinical Utility and User Perceptions of a Digital System for Electronic Patient-Reported Symptom Monitoring During Routine Cancer Care: Findings From the PRO-TECT Trial. Â Link to Abstract: https://ascopubs.org/doi/10.1200/CCI.20.00081 Â Â ABSTRACT Â PURPOSE Â During ordinary oncology practice, there is growing interest in using digital tools for remote monitoring of patients’ symptoms. The therapeutic value and user impressions of these devices are both unknown. Â METHODS Â PRO-TECT is a multicenter experiment assessing the use of electronic patient-reported outcomes (ePROs) in persons with advanced and…
Ethan Basch, MD, MSc from Lineberger Comprehensive Cancer Center, University of North Carolina speaks about Clinical Utility and User Perceptions of a Digital System for Electronic Patient-Reported Symptom Monitoring During Routine Cancer Care: Findings From the PRO-TECT Trial. Â Link to Abstract: https://ascopubs.org/doi/10.1200/CCI.20.00081 Â Â ABSTRACT Â PURPOSE Â During ordinary oncology practice, there is growing interest in using digital tools for remote monitoring of patients’ symptoms. The therapeutic value and user impressions of these devices are both unknown. Â METHODS Â PRO-TECT is a multicenter experiment assessing the use of electronic patient-reported outcomes (ePROs) in persons with advanced and…
Nima Sharifi, MD, Director, Center for GU Malignancies Research at the Cleveland Clinic speaks about Gut Microbiome-Dependent Metabolic Pathways and Risk of Lethal Prostate Cancer: Prospective Analysis of a PLCO Cancer Screening Trial Cohort. Link to Article:https://newsroom.clevelandclinic.org/2021/10/28/cleveland-clinic-study-links-gut-microbiome-and-aggressive-prostate-cancer/For the first time, Cleveland Clinic researchers have discovered that diet-related chemicals in the stomach are linked to aggressive prostate cancer, implying that dietary changes could help reduce risk. The study’s findings were published in the journal Cancer Epidemiology, Biomarkers & Prevention.While further research is needed, lead author Nima Sharifi, M.D., believes the findings from the team’s review of over 700 individuals could have…
Nima Sharifi, MD, Director, Center for GU Malignancies Research at the Cleveland Clinic speaks about Gut Microbiome-Dependent Metabolic Pathways and Risk of Lethal Prostate Cancer: Prospective Analysis of a PLCO Cancer Screening Trial Cohort.Link to Article:https://newsroom.clevelandclinic.org/2021/10/28/cleveland-clinic-study-links-gut-microbiome-and-aggressive-prostate-cancer/For the first time, Cleveland Clinic researchers have discovered that diet-related chemicals in the stomach are linked to aggressive prostate cancer, implying that dietary changes could help reduce risk. The study’s findings were published in the journal Cancer Epidemiology, Biomarkers & Prevention.While further research is needed, lead author Nima Sharifi, M.D., believes the findings from the team’s review of over 700 individuals could have therapeutic…
Dr. Leora Horn, having recently moved from academic medicine to AstraZeneca, talks with hosts Charu Aggarwal & Jack West about the decision to change roles, her efforts to balance work & family, & how to cultivate opportunities for junior faculty.